Your browser doesn't support javascript.
loading
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.
Deodhar, Atul; Gensler, Lianne S; Kay, Jonathan; Maksymowych, Walter P; Haroon, Nigil; Landewé, Robert; Rudwaleit, Martin; Hall, Stephen; Bauer, Lars; Hoepken, Bengt; de Peyrecave, Natasha; Kilgallen, Brian; van der Heijde, Désirée.
Afiliação
  • Deodhar A; Oregon Health & Science University, Portland.
  • Gensler LS; University of California, San Francisco.
  • Kay J; UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester.
  • Maksymowych WP; University of Alberta, Edmonton, Alberta, Canada.
  • Haroon N; University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Landewé R; Academic Medical Center and Zuyderland Medical Center, Heerlen, The Netherlands.
  • Rudwaleit M; Klinikum Bielefeld, Bielefeld, Germany.
  • Hall S; Cabrini Medical Centre, Monash University, and Emeritus Research, Melbourne, Victoria, Australia.
  • Bauer L; UCB Pharma, Monheim am Rhein, Germany.
  • Hoepken B; UCB Pharma, Monheim am Rhein, Germany.
  • de Peyrecave N; UCB Pharma, Brussels, Belgium.
  • Kilgallen B; UCB Pharma, Raleigh, North Carolina.
  • van der Heijde D; Leiden University Medical Center, Leiden, The Netherlands.
Arthritis Rheumatol ; 71(7): 1101-1111, 2019 07.
Article em En | MEDLINE | ID: mdl-30848558
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondiloartropatias / Sacroileíte / Certolizumab Pegol / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondiloartropatias / Sacroileíte / Certolizumab Pegol / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos